TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Injectable Semaglutide Shortage Forces Physicians to Pivot
WEBFeb 5, 2024 · And across the Atlantic, the European Medicines Agency has also put out a notice on a shortage of injectable semaglutide—specifically the Ozempic prefilled pens at doses of 0.25, 0.5, and 1 mg—due to both burgeoning demand and manufacturing issues. The agency said the shortfall is expected to continue through this year.
Nitrates and Erectile Dysfunction Meds? Increasingly Common, …
WEBApr 20, 2022 · By L.A. McKeown. Despite widely publicized warnings about the potential interaction between nitrates prescribed for angina and oral (phosphodiesterase type 5) PDE5 inhibitors taken for erectile dysfunction, a Danish study suggests that prescriptions for the latter have steadily increased over the last 20 years in men who take nitrates, but ...
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
WEBAug 28, 2024 · Now, according to the manufacturer, it will also be available in 2.5-mg and 5-mg single-dose vials at a cost that’s at least 50% lower than the other GLP-1 drugs on the market. Specifically, 4-week supplies of the 2.5-mg and 5-mg single-dose vials are priced at $399 and $549, respectively. According to GoodRx, the retail price for four ...
Blood Pressure Insights in COVID-19: Watch for Drops and RAAS …
WEBSep 10, 2020 · Here, Baher Al-Abbasi, MD (University of Miami/JFK Medical Center, Atlantis, FL), and colleagues noted increased in-hospital mortality in 172 COVID-19 patients taking ACE inhibitors or ARBs compared with those not taking the drugs (33% vs 13%; P = 0.003), as well as increased likelihood of admission to the …
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study
WEBAug 1, 2024 · By Todd Neale. Through one, two, or three doses of COVID-19 vaccine, people who receive the shots generally see lower risks of overall arterial and venous thrombotic events, according to a study of nearly 46 million people living in England. The incidence of major events like acute MI, acute ischemic stroke, pulmonary embolism, and deep venous ...
New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides
WEBAug 21, 2019 · For managing hypertriglyceridemia (200-499 mg/dL), the AHA experts state that prescription-strength omega-3 fatty acids, either with eicosapentaenoic acid (EPA) or EPA plus docosapentaenoic acid (DHA), would be expected to yield a 20% to 30% reduction in triglycerides without any increase in LDL cholesterol.
‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry
WEBJan 10, 2020 · With a list price of $225,000 per year, tafamidis is the most expensive cardiovascular drug on the market. Mathew Maurer, MD (Columbia University Irving Medical Center, New York, NY), who published his views along with Jerry Gurwitz, MD (University of Massachusetts Medical School, Worcester), January …